You are here

Article metrics

Article menu
Clinical/translational cancer immunotherapy
FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy

 

Online download statistics by month:

Online download statistics by month: November 2022 to March 2026

AbstractFullPdf
Nov 202213711377507
Dec 2022452454153
Jan 2023349352111
Feb 202329930481
Mar 2023314316105
Apr 202323423578
May 202320921047
Jun 202326126481
Jul 202323523590
Aug 202322222577
Sep 202321221369
Oct 202317717797
Nov 202320921081
Dec 202318418568
Jan 202413313462
Feb 202413313346
Mar 202421221291
Apr 2024180180100
May 202417717768
Jun 202413714068
Jul 202415415549
Aug 202410510850
Sep 202410810860
Oct 202415615664
Nov 202415715963
Dec 202419119574
Jan 202513213463
Feb 202514314345
Mar 202511111261
Apr 202513914068
May 2025878775
Jun 2025464633
Jul 2025110
Aug 2025110
Dec 2025110
Mar 2026110
Total723372802785